VBI VACCINES INC (VBIV) Stock Analyst Earnings Estimates
NASDAQ:VBIV - Nasdaq - CA91822J2020 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 630K -40.57% | 1.08M 71.43% | 8.682M 703.89% | 13.101M 50.90% | 34.805M 165.67% | 60.017M 72.44% | |
| EBITDA YoY % growth | -66.19M -57.71% | -79.76M -20.50% | -53.321M 33.15% | N/A | N/A | N/A | |
| EBIT YoY % growth | -68.03M -55.96% | -81.82M -20.27% | -55.311M 32.40% | -38.258M 30.83% | -20.415M 46.64% | -15.604M 23.57% | |
| Operating Margin | -10,798.41% | -7,575.93% | -637.08% | -292.02% | -58.66% | -26.00% | |
| EPS YoY % growth | -0.27 -28.57% | -0.43 -59.26% | -9.29 -2,060.47% | -1.25 86.50% | -0.29 77.24% | -0.23 17.86% |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 93.54% | -0.22 77.78% | -0.15 -1,430.00% | -0.12 83.23% | -0.09 71.88% | -0.05 77.27% | -0.03 80.00% |
| Revenue Q2Q % growth | 3.253M 351.81% | 3.955M -40.29% | 4.655M 445.72% | 6.68M 450.25% | 7.959M 144.67% | 9.475M 139.57% | 10.691M 129.67% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.044M 40.81% | -9.259M -43.10% | -8.479M 31.42% | -6.718M 42.84% | -5.707M 43.18% | -4.465M 51.78% | -3.527M 58.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -0.73 77.33% | -0.54 | -0.19 | -35.04% |
| Q4 2023 Q2Q % growth | -0.01 87.50% | -0.22 | 0.21 | 95.54% |
| Q3 2023 Q2Q % growth | -1.01 -1,022.22% | -0.14 | -0.87 | -607.28% |
| Q2 2023 Q2Q % growth | -5.05 -2,705.56% | -2.20 | -2.85 | -129.21% |
| Q1 2023 Q2Q % growth | -3.22 -3,925.00% | -1.28 | -1.95 | -152.55% |
| Q4 2022 Q2Q % growth | -0.08 -14.29% | -0.07 | -0.01 | -12.04% |
| Q3 2022 Q2Q % growth | -0.09 -50.00% | -0.08 | -0.01 | -10.29% |
| Q2 2022 Q2Q % growth | -0.18 -157.14% | -0.07 | -0.11 | -152.10% |
| Q1 2022 Q2Q % growth | -0.08 -14.29% | -0.08 | 0.00 | 1.96% |
| Q4 2021 Q2Q % growth | -0.07 -16.67% | -0.07 | 0.00 | 6.41% |
| Q3 2021 Q2Q % growth | -0.06 | -0.07 | 0.01 | 15.97% |
| Q2 2021 Q2Q % growth | -0.07 -75.00% | -0.06 | -0.01 | -21.10% |
| Q1 2021 Q2Q % growth | -0.07 -40.00% | -0.06 | -0.01 | -14.38% |
| Q4 2020 Q2Q % growth | -0.06 -200.00% | -0.06 | 0.00 | -1.42% |
| Q3 2020 Q2Q % growth | -0.06 60.00% | -0.05 | -0.01 | -30.72% |
| Q2 2020 Q2Q % growth | -0.04 69.23% | -0.04 | 0.00 | 1.96% |
| Q1 2020 Q2Q % growth | -0.05 66.67% | -0.06 | 0.01 | 21.57% |
| Q4 2019 Q2Q % growth | -0.02 | -0.06 | 0.04 | 65.90% |
| Q3 2019 Q2Q % growth | -0.15 | -0.13 | -0.02 | -16.10% |
| Q2 2019 Q2Q % growth | -0.13 | -0.14 | 0.01 | 8.96% |
| Q1 2019 Q2Q % growth | -0.15 | -0.16 | 0.01 | 4.09% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 1.214M 150.31% | 2.909M | -1.695M | -58.27% |
| Q4 2023 Q2Q % growth | 853K 194.14% | 5.467M | -4.614M | -84.40% |
| Q3 2023 Q2Q % growth | 6.624M 1,970.00% | 13.516M | -6.892M | -50.99% |
| Q2 2023 Q2Q % growth | 720K 105.71% | 947.58K | -227.58K | -24.02% |
| Q1 2023 Q2Q % growth | 485K 273.08% | 833.34K | -348.34K | -41.80% |
| Q4 2022 Q2Q % growth | 290K 262.50% | 2.019M | -1.729M | -85.64% |
| Q3 2022 Q2Q % growth | 320K 190.91% | 1.319M | -999K | -75.74% |
| Q2 2022 Q2Q % growth | 350K 150.00% | 718.417K | -368.417K | -51.28% |
| Q1 2022 Q2Q % growth | 130K -56.67% | 88.403K | 41.597K | 47.05% |
| Q4 2021 Q2Q % growth | 80K -50.00% | 140.077K | -60.077K | -42.89% |
| Q3 2021 Q2Q % growth | 110K -63.33% | 207.743K | -97.743K | -47.05% |
| Q2 2021 Q2Q % growth | 140K -22.22% | 490.957K | -350.957K | -71.48% |
| Q1 2021 Q2Q % growth | 300K -28.57% | 494.7K | -194.7K | -39.36% |
| Q4 2020 Q2Q % growth | 160K -71.93% | 414.732K | -254.732K | -61.42% |
| Q3 2020 Q2Q % growth | 300K -53.85% | 334.815K | -34.815K | -10.40% |
| Q2 2020 Q2Q % growth | 180K -71.88% | 647.7K | -467.7K | -72.21% |
| Q1 2020 Q2Q % growth | 420K 16.67% | 668.355K | -248.355K | -37.16% |
| Q4 2019 Q2Q % growth | 570K | 744.345K | -174.345K | -23.42% |
| Q3 2019 Q2Q % growth | 650K | 716.723K | -66.723K | -9.31% |
| Q2 2019 Q2Q % growth | 640K | 498.78K | 141.22K | 28.31% |
| Q1 2019 Q2Q % growth | 360K | 354.96K | 5.04K | 1.42% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 31.91% | 0% | -50% |
| Revenue | 0% | 0% | 0% | -35.27% |